Ipca Laboratories Ltd

Ipca Laboratories Earnings Call Transcript: Key Takeaways

Ipca reported strong Q1FY27 with 21% consolidated revenue growth and EBITDA margins expanding 449bps to 22.88%. Management raised full-year growth and margin guidance based on robust generic and domestic performance.

Call

Guides 16% growth

Ipca Laboratories Annual General Meeting

Ipca Laboratories held its 76th Annual General Meeting, covering the adoption of financial statements, dividend declaration, and director appointments. No voting results were included.

Ipca Laboratories Q1 FY27 Results: Net Profit ₹424.3 Cr, Up 82.2% YoY

Ipca Laboratories Ltd reported revenue from operations of ₹2,788 Cr (+20.8% YoY) and net profit of ₹424.3 Cr (+82.2% YoY) for Q1 FY27.

Key figure

Net profit ₹424.3 Cr · +82.2% YoY

Ipca Laboratories Board Meeting Date

Ipca Laboratories scheduled a Board meeting for August 13, 2026. The board will consider standalone and consolidated financial results for the first quarter.

Ipca Laboratories Dividend

Ipca Laboratories fixed August 7, 2026, as the record date for a Rs. 6 per share dividend. Payment will occur by September 10, 2026.

Ipca Laboratories Annual General Meeting

Ipca Laboratories will hold its 76th AGM on August 13, 2026, via video conferencing. The board recommended a Rs. 6 per share final dividend for shareholders.

Ipca Laboratories Business Update

Ipca Laboratories submitted its Business Responsibility and Sustainability Report for FY 2025-26. The report details environmental, social, and governance disclosures forming part of its Annual Report.

Ipca Laboratories Annual Report

Ipca Laboratories released its Annual Report for FY 2025-26. The report includes financial highlights, the Directors' Report, and Business Responsibility & Sustainability reporting.